0001104659-21-027241.txt : 20210325 0001104659-21-027241.hdr.sgml : 20210325 20210224101044 ACCESSION NUMBER: 0001104659-21-027241 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IBERE PHARMACEUTICALS CENTRAL INDEX KEY: 0001835205 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 981564986 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2005 MARKET STREET, SUITE 2030 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-765-3222 MAIL ADDRESS: STREET 1: 2005 MARKET STREET, SUITE 2030 CITY: PHILADELPHIA STATE: PA ZIP: 19103 CORRESP 1 filename1.htm

February 24, 2021

VIA EDGAR

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attn: Todd K. Schiffman

Re:	Ibere Pharmaceuticals
	Registration Statement on Form S-1
	Filed February 9, 2021, as amended
	File No. 333-252863

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for themselves and the other underwriters, hereby join in the request of Ibere Pharmaceuticals that the effective date of the above-referenced registration statement be accelerated so as to permit it to become effective at 4:00 p.m. Eastern time on Thursday, February 25, 2021, or as soon thereafter as practicable.

Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advise that as of the date hereof, approximately 550 copies of the preliminary prospectus dated February 22, 2021 have been distributed to prospective underwriters and dealers, institutional investors, retail investors and others.

Each of the undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature page follows]

	Very truly yours,

	RAYMOND JAMES & ASSOCIATES, INC.

	By:	/s/ Justin Roman
	Name:	Justin Roman
	Title:	Director

	As representative of the underwriters